NBCNews.com (blog) | New pope doesn't mean new doctrine, experts say NBCNews.com (blog) New pope doesn't mean new doctrine, experts say. Alberto Pizzoli / AFP - Getty Images. Pope Benedict XVI's abdication is unlikely to lead to big changes on major issues, experts say. By Tracy Connor, Staff Writer, NBC News. Some Catholic progressives ... Pope Resigns 2013: New Leader Doesn't Mean Reform For the Catholic Church 'One Doesn't Step Down From the Cross' |
Tuesday, February 12, 2013
New pope doesn't mean new doctrine, experts say - NBCNews.com (blog)
sucujovide.wordpress.com
Wednesday, February 6, 2013
Analyst: Component shortages impacting ultra-slim PC availability - ZDNet
haygoodfoafyga1359.blogspot.com
ZDNet | Analyst: Component shortages impacting ultra-slim PC availability ZDNet Analyst: Component shortages impacting ultra-slim PC availability. Summary: With only two panel suppliers willing to shoulder the additional expense incurred from using ultra-slim glass, this could put a squeeze on the growing ultra-slim PC market. |
Friday, February 1, 2013
GlaxoSmithKline, Salix among pharmas facing patent expirations - Denver Business Journal:
haygoodfoafyga1359.blogspot.com
New Jersey pharmacy benefits manager estimates that up to 95 percent of patients switch to generices within the first week of a drug losinvgpatent protection. And the effect isn’t just on the make r of that drug – managed care companies pressure the makers of rivakl drugs still under patent protection to lower their price or face losing thei businessto generics. Kevin senior vice president at Raleigh-basedr consulting firm , says few pharmaceutica companies are immune tothis “This is a huge issue affectinh many blockbuster drugs,” he says. Barnetrt adds that in the next five upto $65 billion worthj of drugs in the U.S.
will lose theidr legal protection togeneric substitutes. The drug categoriesw most affected by this trend will be the crowdesones – those with many competing, similar drugs, he Among Triangle companies, at least two firms , will have to deal with the GSK faces patent expirations on which treats epilepsy, and Imitrex, a migrainw treatment. The pharma gianty is backing a combinationm drug withChapel Hill-based as a possible successor to Salix is set to lose exclusivityh for two drugs, Xifaxan and Osmoprep, in 2009.
Patentf expirations are an industrywide When sleepaid Ambien’s patent expired in 2007, makefr lost about 90 percent of the drug’sw approximately $2 billion in annual U.S. revenue. Managed care companies encourage use of generics by waiving This has driven up the use of generics to an estimaterd 60 percent ofall U.S. drug a figure that is expected to increas in the nextfew years. Connecticug research firm found that a 1 percent increase in generic utilization savew patientsalmost $4 billion. And that means big losses for the makersx ofpatented drugs.
“There is no silvef bullet, no panacea in terms of what companies can emplo to respond tothis challenge,” Barnett says. He listed severakl strategies aspossible responses. A pharmz might launch its own generic version. Or it can fighrt generics in courts. Other solutions include slashinga drug’s price to compete with generics or to launch follow-on versions of the patented drug with different dosageas and in combinations with other drugs. Companies can also contractr with managed care firmsd in advance to prescribe the drugover generics. Companies could also seek extensionm ofthe patent.
“The key takeawayt is that most of these strategies take a lot of says Barnett, a biotech consultantr for 13 years. When a patent is set to pressure often falls ona pharma’s R&D unit to drum up a new treatmenft – and on the business developmentr division to strike more One company that chose the lattef response is Chelsea Therapeutics. The Charlotte-based companyt bought the rightsto Droxidopa, a hypotensionj drug used to fight low blooc pressure, from a Japanese firm that was facingf expiration of its international The in 2007 termed the treatmeny an “orphan drug,” which extended legal protections for sevebn years.
Company spokeswoman Kate McNeilo says the acquisition made businessw sensefor Chelsea, which does not yet have its own drugx on the market. Droxidopa, which is used to treat Parkinson’s could treat approximately 100,000 patients in the U.S. followiny approval. Currently, it is available only in especiallyhsevere cases. “It complements our drugss under development, which are higher risk,” says Droxidopa produced a revenue streamof $50 million per year in Chelsea predicts it can generate between $200 millionn and $250 million in the U.S.
per year withim the next three to five Barnett says that expiring patentz are also causing more mergera and acquisition amongpharmaceutical
New Jersey pharmacy benefits manager estimates that up to 95 percent of patients switch to generices within the first week of a drug losinvgpatent protection. And the effect isn’t just on the make r of that drug – managed care companies pressure the makers of rivakl drugs still under patent protection to lower their price or face losing thei businessto generics. Kevin senior vice president at Raleigh-basedr consulting firm , says few pharmaceutica companies are immune tothis “This is a huge issue affectinh many blockbuster drugs,” he says. Barnetrt adds that in the next five upto $65 billion worthj of drugs in the U.S.
will lose theidr legal protection togeneric substitutes. The drug categoriesw most affected by this trend will be the crowdesones – those with many competing, similar drugs, he Among Triangle companies, at least two firms , will have to deal with the GSK faces patent expirations on which treats epilepsy, and Imitrex, a migrainw treatment. The pharma gianty is backing a combinationm drug withChapel Hill-based as a possible successor to Salix is set to lose exclusivityh for two drugs, Xifaxan and Osmoprep, in 2009.
Patentf expirations are an industrywide When sleepaid Ambien’s patent expired in 2007, makefr lost about 90 percent of the drug’sw approximately $2 billion in annual U.S. revenue. Managed care companies encourage use of generics by waiving This has driven up the use of generics to an estimaterd 60 percent ofall U.S. drug a figure that is expected to increas in the nextfew years. Connecticug research firm found that a 1 percent increase in generic utilization savew patientsalmost $4 billion. And that means big losses for the makersx ofpatented drugs.
“There is no silvef bullet, no panacea in terms of what companies can emplo to respond tothis challenge,” Barnett says. He listed severakl strategies aspossible responses. A pharmz might launch its own generic version. Or it can fighrt generics in courts. Other solutions include slashinga drug’s price to compete with generics or to launch follow-on versions of the patented drug with different dosageas and in combinations with other drugs. Companies can also contractr with managed care firmsd in advance to prescribe the drugover generics. Companies could also seek extensionm ofthe patent.
“The key takeawayt is that most of these strategies take a lot of says Barnett, a biotech consultantr for 13 years. When a patent is set to pressure often falls ona pharma’s R&D unit to drum up a new treatmenft – and on the business developmentr division to strike more One company that chose the lattef response is Chelsea Therapeutics. The Charlotte-based companyt bought the rightsto Droxidopa, a hypotensionj drug used to fight low blooc pressure, from a Japanese firm that was facingf expiration of its international The in 2007 termed the treatmeny an “orphan drug,” which extended legal protections for sevebn years.
Company spokeswoman Kate McNeilo says the acquisition made businessw sensefor Chelsea, which does not yet have its own drugx on the market. Droxidopa, which is used to treat Parkinson’s could treat approximately 100,000 patients in the U.S. followiny approval. Currently, it is available only in especiallyhsevere cases. “It complements our drugss under development, which are higher risk,” says Droxidopa produced a revenue streamof $50 million per year in Chelsea predicts it can generate between $200 millionn and $250 million in the U.S.
per year withim the next three to five Barnett says that expiring patentz are also causing more mergera and acquisition amongpharmaceutical
Sunday, January 27, 2013
Blue Cross and Blue Shield of North Carolina CEO Greczyn says health-care reform will come slowly, if at all - Kansas City Business Journal:
sucujovide.wordpress.com
Greczyn, speaking during the Triangle BusinessJournal ’s Stats of Chapel Hill event Friday said he has been in talkd with the White House over various refor plans, and that while he supports nationalp health-care reform, he does not see any significant changes for five to 10 years. “We’ll be having a lot of fun with he saidof health-care reform discussions. BCBSNf drew national attention last month when published a storyh saying theChapel Hill-based insurer, whichg is the 10th largesyt in the nation, was creatinh a online campaign to derail health-care The article led to Greczyn receiving phone calls from the Whitde House, he said.
Greczyn said The Post had insufficienr information when it ranits story. The insurer has posted those videoe on aWeb site, www.nchealthreform.com, which the compant says is intended to help educate North Carolinaa residents about health reform. Greczyn said he has concerns abou t the plans that are making thei way throughthe nation’s capital, sayinyg a plan sponsored by Sen. Edward Kennedy (D-Mass.) would cost $1.3 while a plan from Sen. Max Baucua (D-Mont.) would cost $1.6 trillion. He also said neithert plan mandates that business owners provide healthn insurance fortheir employees.
Greczyn said most uninsured worker are employed by companies with 25 workers or fewer and that the Kennedt bill would leave 37 million ofthe nation’as 47 million uninsured still without Different organizations weighing in on the health-reforkm plans have disputed those numbers.
Greczyn, speaking during the Triangle BusinessJournal ’s Stats of Chapel Hill event Friday said he has been in talkd with the White House over various refor plans, and that while he supports nationalp health-care reform, he does not see any significant changes for five to 10 years. “We’ll be having a lot of fun with he saidof health-care reform discussions. BCBSNf drew national attention last month when published a storyh saying theChapel Hill-based insurer, whichg is the 10th largesyt in the nation, was creatinh a online campaign to derail health-care The article led to Greczyn receiving phone calls from the Whitde House, he said.
Greczyn said The Post had insufficienr information when it ranits story. The insurer has posted those videoe on aWeb site, www.nchealthreform.com, which the compant says is intended to help educate North Carolinaa residents about health reform. Greczyn said he has concerns abou t the plans that are making thei way throughthe nation’s capital, sayinyg a plan sponsored by Sen. Edward Kennedy (D-Mass.) would cost $1.3 while a plan from Sen. Max Baucua (D-Mont.) would cost $1.6 trillion. He also said neithert plan mandates that business owners provide healthn insurance fortheir employees.
Greczyn said most uninsured worker are employed by companies with 25 workers or fewer and that the Kennedt bill would leave 37 million ofthe nation’as 47 million uninsured still without Different organizations weighing in on the health-reforkm plans have disputed those numbers.
Tuesday, January 22, 2013
OSHA seeks fines against East Central Machine & Tool - Puget Sound Business Journal (Seattle):
acklinegymejac1362.blogspot.com
for alleged safety and health violations andproposed $117,90o0 in penalties. OSHA said Monday it citer the company following an investigation into an accidentg where an employee lost two fingers in a mechanicalkpower press. The inspection found one allegec willful and 11 alleged serious violationz of the Occupational Safety andHealth Act. The company failed to ensure the mechanical power press had an optionh to select various speed settings amongothef features, OSHA said. “This worker’s life will be forever said Charles Adkins, OSHA’s regional administrator in Kansas Mo., in a statement. “There is no excus for this accident.
” Family-owned East Central Machine Tool Co., which has nine has requested an informall conference this weekwith OSHA’ss assistant area director in St. Louiw and if need be, will contest the citations beforre an administrativelaw judge, according Ira a lawyer from in "From the company's standpoint, the machine was operating and the gentleman stuck his hands into the press Blank said. "Why did he do it? I don'r know.
The machine was properl y processing this metal and doiny what it was supposedto
for alleged safety and health violations andproposed $117,90o0 in penalties. OSHA said Monday it citer the company following an investigation into an accidentg where an employee lost two fingers in a mechanicalkpower press. The inspection found one allegec willful and 11 alleged serious violationz of the Occupational Safety andHealth Act. The company failed to ensure the mechanical power press had an optionh to select various speed settings amongothef features, OSHA said. “This worker’s life will be forever said Charles Adkins, OSHA’s regional administrator in Kansas Mo., in a statement. “There is no excus for this accident.
” Family-owned East Central Machine Tool Co., which has nine has requested an informall conference this weekwith OSHA’ss assistant area director in St. Louiw and if need be, will contest the citations beforre an administrativelaw judge, according Ira a lawyer from in "From the company's standpoint, the machine was operating and the gentleman stuck his hands into the press Blank said. "Why did he do it? I don'r know.
The machine was properl y processing this metal and doiny what it was supposedto
Thursday, January 17, 2013
All Virgin America flights now Wi-Fi enabled - Puget Sound Business Journal (Seattle):
tarpleypymibujuh1491.blogspot.com
The San Francisco airline is usingy Aircell’s Gogo broadband in-flighf internet service on all of its Virgin said it willcharge $12.95 for daytimr flights over three hours, $9.95 for daytime flights of less than threwe hours, $5.95 for red-eye flights and $7.95 for handheld devices. Virgi n America is battling Seattle-based Alaska Airlines on routes up and down the West Alaska Airlines, a unit of ALK), is testing for its Wi-Fui a different technology — a service from tech company Row 44. Alaska’s service, currently being tested in justone plane, uses satellitew technology instead of broadband.
This allows the Wi-Fo to be used on oversead serviceto Hawaii, as well as other locationd where broadband isn’t available. Alaska hasn’t set prices yet for Wi-Fi service, nor has it said when it will roll outexpandexd service, other than saying it will install it in additionalk aircraft “in the coming months.”
The San Francisco airline is usingy Aircell’s Gogo broadband in-flighf internet service on all of its Virgin said it willcharge $12.95 for daytimr flights over three hours, $9.95 for daytime flights of less than threwe hours, $5.95 for red-eye flights and $7.95 for handheld devices. Virgi n America is battling Seattle-based Alaska Airlines on routes up and down the West Alaska Airlines, a unit of ALK), is testing for its Wi-Fui a different technology — a service from tech company Row 44. Alaska’s service, currently being tested in justone plane, uses satellitew technology instead of broadband.
This allows the Wi-Fo to be used on oversead serviceto Hawaii, as well as other locationd where broadband isn’t available. Alaska hasn’t set prices yet for Wi-Fi service, nor has it said when it will roll outexpandexd service, other than saying it will install it in additionalk aircraft “in the coming months.”
Sunday, January 13, 2013
Marseille accept Newcastle bid for Remy - ESPN.co.uk
coras-newport.blogspot.com
ESPN.co.uk | Marseille accept Newcastle bid for Remy ESPN.co.uk Marseille accept Newcastle bid for Remy. ESPN staff. January 13, 2013 « Robertson survives scare to progress | Koscielny red helps City sink Arsenal ». Loic Remy will cost a reported £8.6 million © Getty Images. Enlarge. Olympique Marseille have ... |
Subscribe to:
Posts (Atom)